Phase 2 study

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Betta Pharmaceuticals Co., Ltd.
Registry number NCT07435038
Started 29 January 2026 Today 16 October 2026 Estimated completion 28 December 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Blacktown Hospital Blacktown NSW Not yet recruiting
Scientia Clinical Research Randwick NSW Not yet recruiting
GenesisCare St Leonards, 7 Westbourne St, St Leonards Sydney NSW Not yet recruiting
Southern Oncology Clinical Research Unit (SOCRU) Bedford Park SA Not yet recruiting
Warringal Private Hospital Heidelberg VIC Not yet recruiting
Linear Clinical Research Ltd Nedlands WA Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 120

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Histologically confirmed advanced solid tumor with RAS mutations identified through deoxyribonucleic acid (DNA) sequencing.

* Have received prior standard therapy appropriate for tumor type and stage.

* Have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 Adequate organ function.

Exclusion Criteria:

* Primary central nervous system (CNS) tumors active and untreated brain metastases.

* Known or suspected impairment of gastrointestinal function that may prohibit ability to swallow or absorb an oral medication.

* History of any other unstable or clinically significant concurrent medical condition that would, in the opinion of the investigator, jeopardize the safety of a participant, impact their expected survival through the end of the study participation, and/or impact their ability to comply with the protocol prior/concomitant therapy

Dates on the record

Started 29 January 2026
Estimated completion 28 December 2028
Registry last updated 18 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 18 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.